Implementing a Gold Standard FSP Strategic Partnership to Fuel Efficient Drug Development

1 minute read

Published: March 7th, 2024

Complete the form below to watch the webinar

Featuring:

  • Francis Kendall, Head of Oncology Statistical Programming, Biometrics, Oncology R&D, AstraZeneca
  • Alan Salter, Director, R&D Clinical Partner Management, Takeda
  • Ping-Chung Chang, Head Business Transformation, Phastar
  • Elisa Mansfield, Vice President, FSP, Phastar

Moderated by Natalie Fforde, Senior Vice President, Global Strategic Partnerships, Phastar

Related articles

Driving Clinical Research with AI: From Early Discovery to Regulatory-Grade Insights

Driving Clinical Research with AI: From Early Discovery to Regulatory-Grade Insights

May 19th, 2026 1 minute read

Join us for a transformative three-part webinar series, “Driving Clinical Research with AI,” where indust...

Causal Inference Through a Regulatory Lens

Causal Inference Through a Regulatory Lens

May 15th, 2026 1 minute read

About This Webinar As expectations for robust, real-world evidence continue to grow, understanding how regulators eva...

From Data to Decisions: TMLE, Doubly Robust Methods, and Federated Learning

From Data to Decisions: TMLE, Doubly Robust Methods, and Federated Learning

April 13th, 2026 1 minute read

This webinar will cover methods that are crucial to making informed decisions. Specifically, personalized care throug...